oxidopamine has been researched along with Myocardial Ischemia in 3 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Yohimbine was antiarrhythmic in the presence and absence of platelets, suggesting direct myocardial effects, but BN 52021 had no antiarrhythmic effects." | 1.29 | Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects. ( Flores, NA; Goulielmos, NV; Seghatchian, MJ; Sheridan, DJ, 1994) |
| "Reserpine pretreatment did not affect the response to ischaemia or to preconditioning, although LDH release tended to be greater than in normal hearts, especially in the non-preconditioned group." | 1.29 | Endogenous catecholamines are not necessary for ischaemic preconditioning in the isolated perfused rat heart. ( Baird, AJ; Dzwonczyk, S; Grover, GJ; Murray, HN; Sleph, PG; Weselcouch, EO, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Béguin, PC | 1 |
| El-Helou, V | 1 |
| Gillis, MA | 1 |
| Duquette, N | 1 |
| Gosselin, H | 1 |
| Brugada, R | 1 |
| Villeneuve, L | 1 |
| Lauzier, D | 1 |
| Tanguay, JF | 1 |
| Ribuot, C | 1 |
| Calderone, A | 1 |
| Flores, NA | 1 |
| Goulielmos, NV | 1 |
| Seghatchian, MJ | 1 |
| Sheridan, DJ | 1 |
| Weselcouch, EO | 1 |
| Baird, AJ | 1 |
| Sleph, PG | 1 |
| Dzwonczyk, S | 1 |
| Murray, HN | 1 |
| Grover, GJ | 1 |
3 other studies available for oxidopamine and Myocardial Ischemia
| Article | Year |
|---|---|
Nestin (+) stem cells independently contribute to neural remodelling of the ischemic heart.
Topics: Adrenergic Fibers; Adult Stem Cells; Animals; Cell Differentiation; Cell Lineage; Disease Models, An | 2011 |
Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects.
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Biphenyl Compounds; Blood Platelets; Colforsin; Diterpenes; | 1994 |
Endogenous catecholamines are not necessary for ischaemic preconditioning in the isolated perfused rat heart.
Topics: Animals; Catecholamines; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Ischemia; | 1995 |